Followers | 74 |
Posts | 7298 |
Boards Moderated | 0 |
Alias Born | 09/09/2009 |
Friday, March 16, 2018 4:25:18 PM
"4.6
Change in Control.
On September 5, 2017, pursuant to our Stock Purchase Agreement, we entered into a stock sale and business development transaction with Harry Orfanos; whereby, Mr. Orfanos would acquire control of the Company by Mr. Townsend issuance to him of 35,000,000 shares of our Preferred Stock (“Control Stock”). As the result of this transaction, a change in our control will occur pending successful execution of our Agreement. Our sole officer and director resigned after appointing Mr. Orfanos as our Chairman of the Board, President, and Chief Executive Officer. The consideration for the Preferred Stock is $75,000. Because the securities issued to Mr. Orfanos were debt securities, they did not require registration or qualification in any jurisdiction. We have not subsequently registered the Control Stock; however, the Control Stock does appear on the stock transfer ledger maintained by the company. The Control Stock is not listed on any regional or national exchange, and the Control Stock is not quoted over the counter on any electronic intermediary quotation system."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM